A Randomized, Double-blind Study of the Effect of RO4607381 in Combination With Pravastatin on HDL-cholesterol (HDL-C) Levels in Patients With Low or Average HDL-C Levels

Trial Profile

A Randomized, Double-blind Study of the Effect of RO4607381 in Combination With Pravastatin on HDL-cholesterol (HDL-C) Levels in Patients With Low or Average HDL-C Levels

Completed
Phase of Trial: Phase II

Latest Information Update: 08 Jul 2015

At a glance

  • Drugs Dalcetrapib (Primary) ; Pravastatin
  • Indications Dyslipidaemias; Low HDL cholesterol
  • Focus Therapeutic Use
  • Sponsors Roche
  • Most Recent Events

    • 01 Mar 2012 Results published in the American Heart Journal.
    • 15 Mar 2010 Data presented at 59th Annual Scientific Session of the American College of Cardiology.
    • 18 Jun 2008 Status changed from in progress to completed according to Roche.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top